SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-16-630417
Filing Date
2016-06-24
Accepted
2016-06-23 20:34:03
Documents
4
Period of Report
2016-07-28
Effectiveness Date
2016-06-24

Document Format Files

Seq Description Document Type Size
1 DEF 14A d214701ddef14a.htm DEF 14A 262141
2 GRAPHIC g214701g48x59.jpg GRAPHIC 23592
3 GRAPHIC g214701imga1.jpg GRAPHIC 165529
4 GRAPHIC g214701imga2.jpg GRAPHIC 132467
  Complete submission text file 0001193125-16-630417.txt   706472
Mailing Address 113 CEDAR STREET SUITE 7 MILFORD MA 01757
Business Address 113 CEDAR STREET SUITE 7 MILFORD MA 01757 508-473-5993
Spring Bank Pharmaceuticals, Inc. (Filer) CIK: 0001566373 (see all company filings)

IRS No.: 522386345 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37718 | Film No.: 161729677
SIC: 2834 Pharmaceutical Preparations